Exopharm Ltd
ASX:EX1
Income Statement
Earnings Waterfall
Exopharm Ltd
Income Statement
Exopharm Ltd
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
3
N/A
|
3
-1%
|
4
+56%
|
4
0%
|
4
+0%
|
6
+54%
|
3
-47%
|
1
-65%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(8)
|
(10)
|
(13)
|
(14)
|
(14)
|
(13)
|
(10)
|
(5)
|
|
| Selling, General & Administrative |
(5)
|
(7)
|
(8)
|
(10)
|
(10)
|
(9)
|
(7)
|
(4)
|
|
| Research & Development |
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(1)
|
0
|
(2)
|
0
|
(2)
|
0
|
|
| Operating Income |
(5)
N/A
|
(7)
-42%
|
(8)
-13%
|
(10)
-20%
|
(10)
+2%
|
(7)
+34%
|
(7)
-3%
|
(4)
+39%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(5)
N/A
|
(7)
-41%
|
(8)
-14%
|
(10)
-20%
|
(10)
+1%
|
(7)
+31%
|
(7)
-3%
|
(4)
+39%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(5)
|
(7)
|
(8)
|
(10)
|
(10)
|
(7)
|
(7)
|
(4)
|
|
| Net Income (Common) |
(5)
N/A
|
(7)
-41%
|
(8)
-14%
|
(10)
-20%
|
(10)
+1%
|
(7)
+31%
|
(7)
-3%
|
(4)
+39%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.07
-40%
|
-0.06
+14%
|
-0.06
N/A
|
-0.06
N/A
|
-0.04
+33%
|
-0.04
N/A
|
-0.02
+50%
|
|